Alkermes Announces Notice of Allowance of Key US Patent for Aripiprazole …

Alkermes Announces Notice of Allowance of Key US Patent for Aripiprazole …

Filed under: drug addiction treatment options

"With data from our phase 3 study for aripiprazole lauroxil anticipated in late 2013 and expected patent protection into late 2030, we look forward to advancing aripiprazole lauroxil as a potential new treatment option for patients with schizophrenia …
Read more on DailyFinance

Repligen Announces Licensing Agreement with Pfizer for Spinal Muscular …

Filed under: drug addiction treatment options

The SMA program includes RG3039, a small molecule drug candidate in clinical development for SMA, as well as backup compounds and enabling technologies. Under the terms of the agreement, Repligen is entitled … "There is a critical need to expedite …
Read more on DailyFinance

FDA Approves First Drug to Treat Multi-Drug Resistant Tuberculosis

Filed under: drug addiction treatment options

"Multi-drug resistant tuberculosis poses a serious health threat throughout the world, and Sirturo provides much-needed treatment for patients who have don't have other therapeutic options available," said Edward Cox, M.D., M.P.H, director of the …
Read more on Equities.com

FDA Approves Rebif Rebidose Interferon Beta-1a For Multiple Sclerosis

Filed under: drug addiction treatment options

Merck Serono, a division of Germany's Merck, announced that the U.S. Food and Drug Administration (FDA) approved Rebif(R) Rebidose(R) (interferon beta-1a), a single-use auto-injector for the self-administration of Rebif, a disease-modifying drug used …
Read more on Science 2.0